93 biochemical weapons to decline whenever a medical mercenary offers them to you or your children.
KATHERINE WATT
Bailiwick News
Helpful list from FDA, found while doing research and organizing my files on:
- Public Health Emergency (PHE), Emergency Use Authorization (EUA) and PREP Act notices, declarations, determinations and authorizations issued by HHS Secretaries and their delegees from Jan. 2020 to the present 1;
- Legal advisory opinions about PREP Act liability immunity, issued by the HHS Office of General Counsel from Jan. 2020 to the present 2; and
- Guidance to pharmacists about PREP Act liability immunity, issued by the Office of the Assistant Secretary of Health, from Jan. 2020 to the present. 3
May biochemical weapon uptake rates approach zero in coming months and years, as rational popular response to the truth rendered much more visible since January 2020, and in firm opposition to all “recommendations” of the CDC Advisory Committee on Immunization Practices (ACIP).
Biochemical weapons deployed by injection have been intrinsically injurious from the start of government campaigns promoting their use more than a century ago.
The “Covid-19” weapons have been the most deadly to date, with some lots deadlier than others, and contents of many lots still unidentified.
The US military is now incorporating more toxic compounds into each new batch churned out by the biomunitions production lines, added to the list of FDA-endorsed bioweapons, and recommended by the members of the CDC-ACIP for use on military targets.
- Adenovirus Type 4 and Type 7 Vaccine, Live, Oral – No Trade Name
- Anthrax Vaccine Adsorbed – Biothrax
- BCG Live – BCG Vaccine
- BCG Live – TICE BCG
- Cholera Vaccine Live Oral – Vaxchora
- COVID-19 Vaccine, mRNA – Comirnaty
- COVID-19 Vaccine, mRNA – SPIKEVAX
- Dengue Tetravalent Vaccine, Live – DENGVAXIA
- Diphtheria & Tetanus Toxoids Adsorbed – No Trade Name
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed – Infanrix
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed – DAPTACEL
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed, Hepatitis B (recombinant) and Inactivated Poliovirus Vaccine Combined – Pediarix
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine – KINRIX
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine – Quadracel
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningococcal Protein Conjugate] and Hepatitis B [Recombinant] Vaccine – VAXELIS
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine -Pentacel
- Ebola Zaire Vaccine, Live – ERVEBO
- Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) – PedvaxHIB
- Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) – ActHIB
- Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) – Hiberix
- Hepatitis A Vaccine, Inactivated – Havrix
- Hepatitis A Vaccine, Inactivated – VAQTA
- Hepatitis A Inactivated and Hepatitis B (Recombinant) Vaccine – Twinrix
- Hepatitis B Vaccine (Recombinant) – Recombivax HB
- Hepatitis B Vaccine (Recombinant) – PREHEVBRIO
- Hepatitis B Vaccine (Recombinant) – Engerix-B
- Hepatitis B Vaccine (Recombinant), Adjuvanted – HEPLISAV-B
- Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant – Gardasil
- Human Papillomavirus 9-valent Vaccine, Recombinant – Gardasil 9
- Human Papillomavirus Bivalent (Types 16, 18) Vaccine, Recombinant – Cervarix
- Influenza A (H1N1) 2009 Monovalent Vaccine – No Trade Name
- Influenza A (H1N1) 2009 Monovalent Vaccine – No Trade Name
- Influenza A (H1N1) 2009 Monovalent Vaccine – No Trade Name
- Influenza A (H1N1) 2009 Monovalent Vaccine – No Trade Name
- Influenza A (H1N1) 2009 Monovalent Vaccine – No Trade Name
- Influenza Virus Vaccine, H5N1 (for National Stockpile) – No Trade Name
- Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted – No Trade Name
- Influenza A (H5N1) Monovalent Vaccine, Adjuvanted – AUDENZ
- Influenza Vaccine, Adjuvanted – Fluad Quadrivalent
- Influenza Vaccine, Adjuvanted – Fluad
- Influenza Vaccine – Afluria Quadrivalent, Afluria Quadrivalent Southern Hemisphere
- Influenza Vaccine – Flucelvax Quadrivalent
- Influenza Vaccine – Flulaval Quadrivalent
- Influenza Virus Vaccine (Trivalent, Types A and B) – Afluria, Afluria Southern Hemisphere
- Influenza Virus Vaccine (Trivalent, Types A and B) – FluLaval
- Influenza Vaccine, Live, Intranasal (Trivalent, Types A and B) – FluMist
- Influenza Virus Vaccine (Trivalent, Types A and B) – Fluarix
- Influenza Virus Vaccine (Trivalent, Types A and B) – Fluvirin
- Influenza Virus Vaccine (Trivalent, Types A and B) – Agriflu
- Influenza Virus Vaccine (Trivalent, Types A and B) – Fluzone, Fluzone High-Dose and Fluzone Intradermal
- Influenza Virus Vaccine (Trivalent, Types A and B) – Flucelvax
- Influenza Vaccine (Trivalent) – Flublok
- Influenza Vaccine (Quadrivalent) – Flublok Quadrivalent
- Influenza Vaccine,Live, Intranasal (Quadrivalent, Types A and Types B) – FluMist Quadrivalent
- Influenza Virus Vaccine (Quadrivalent, Types A and Types B) – Fluarix Quadrivalent
- Influenza Virus Vaccine (Quadrivalent, Types A and Types B) – Fluzone Quadrivalent
- Japanese Encephalitis Virus Vaccine, Inactivated, Adsorbed – Ixiaro
- Measles, Mumps and Rubella Vaccine, Live – PRIORIX
- Measles, Mumps, and Rubella Virus Vaccine, Live – M-M-R II
- Measles, Mumps, Rubella and Varicella Virus Vaccine Live – ProQuad
- Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine – MENVEO
- Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine – Menactra
- Meningococcal Group B Vaccine – BEXSERO
- Meningococcal Group B Vaccine – TRUMENBA
- Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined – Menomune-A/C/Y/W-135
- Meningococcal (Groups A, C, Y, W) Conjugate Vaccine – MenQuadfi
- Plague Vaccine – No trade name
- Pneumococcal Vaccine, Polyvalent – Pneumovax 23
- Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) – Prevnar 13
- Pneumococcal 15-valent Conjugate Vaccine – VAXNEUVANCE
- Pneumococcal 20-valent Conjugate Vaccine – Prevnar 20
- Poliovirus Vaccine Inactivated (Human Diploid Cell) – Poliovax
- Poliovirus Vaccine Inactivated (Monkey Kidney Cell) – IPOL
- Rabies Vaccine – Imovax
- Rabies Vaccine – RabAvert
- Rabies Vaccine Adsorbed – No Trade Name
- Rotavirus Vaccine, Live, Oral – ROTARIX
- Rotavirus Vaccine, Live, Oral, Pentavalent – RotaTeq
- Respiratory Syncytial Virus Vaccine, Adjuvanted – AREXVY
- Smallpox and Monkeypox Vaccine, Live, Non-Replicating – JYNNEOS
- Smallpox (Vaccinia) Vaccine, Live – ACAM2000
- Tetanus & Diphtheria Toxoids, Adsorbed – TDVAX
- Tetanus & Diphtheria Toxoids Adsorbed for Adult Use – TENIVAC
- Tetanus Toxoid Adsorbed – No Trade Name
- Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed – Adacel
- Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed – Boostrix
- Tick-Borne Encephalitis Vaccine – TICOVAC
- Typhoid Vaccine Live Oral Ty21a – Vivotif
- Typhoid Vi Polysaccharide Vaccine – TYPHIM Vi
- Varicella Virus Vaccine Live – Varivax
- Yellow Fever Vaccine – YF-Vax
- Zoster Vaccine, Live, (Oka/Merck) – Zostavax
- Zoster Vaccine Recombinant, Adjuvanted – SHINGRIX

PHE, EUA and PREP Act notices (labeled/listed by date notice took effect)
- 2020.02.04 HHS Notice of Determination of Public Health Emergency and Declaration circumstances justify authorization emergency use Covid tests, 85 FR 7316, filed 2020.02.06
- 2020.02.04 HHS Original PREP Act Notice of Declaration, liability, medical countermeasures, qualified persons, population, geographic 85 FR 15198, signed 2020.03.10
- 2020.03.27 HHS PREP Act Amendment 1, expanded description of covered countermeasures, signed 2020.04.10, 85 FR 21012
- 2020.02.04 HHS PREP Act Amendment 2, qualified pandemic epidemic products limit harm otherwise caused, signed 2020.06.04, 85 FR 35100
- 2020.08.24 HHS PREP Act Amendment 3, qualified persons, add pharmacists, pharmacy technicians, order and administer any childhood vaccine age 3 to 18, add category threat posed by decreased childhood vaccinations, signed 2020.08.19, 85 FR 52136
- 2020.02.04 PREP Act Amendment 4, covered countermeasures, full printing of amended declaration 85 FR 79190, signed 2020.12.03
- 2020.03.02 HHS Notice of Declaration circumstances justify authorization emergency use personal respiratory device NIOSH mask, 85 FR 13907, filed 2020.03.09
- 2020.03.24 HHS Notice of Declaration circumstances justify authorization emergency use medical devices, 85 FR 17335
- 2020.03.27 HHS Notice of Declaration circumstances justify authorization emergency use drugs and biological products, 85 FR 18250
- 2020.11.25 HHS Original PREP Act Notice of Declaration Marburg disease marburgvirus ebola hemorrhagic, 85 FR 79198
- 2020.12.11 HHS FDA Hinton EUA, Pfizer eff 2020.12.11, Moderna eff 2020.12.18, dated 2021.01.12, 86 FR 5200
- 2021.02.02 HHS PREP Act Amendment 5, additional qualified persons vaccines incl physicians and nurses license lapsed 5 years or less, filed 2021.01.29, 86 FR 7872
- 2021.02.16 HHS PREP Act Amendment 6, additional qualified persons vaccines federal employees contractors volunteers, filed 2021.02.11, 86 FR 9516
- 2021.02.02 HHS PREP Act Amendment 5 and 6 Technical Correction, additional qualified persons uniformed service members eff 2021.02.16, filed 2021.02.19 86 FR 10588
- 2021.03.11 HHS PREP Act Amendment 7, additional qualified persons vaccines midwives, dentists, paramedic, EMTs, respiratory therapist, podiatrist, veterinarians, licensed, less than 5 years lapsed, students, interns, signed 2021.03.10, 86 FR 14463
- 2021.07.30 HHS PREP Act Amendment 8, qualified persons, pharmacist, pharmacy technicians, administer seasonal influenza vaccines to adults, 86 FR 41978
- 2021.09.14 HHS PREP Act Amendment 9, expand qualified persons, pharmacists, pharmacy technicians, pharmacy interns administer Covid therapeutics, monoclonal antibody paxlovid, signed 2021.09.09, 86 FR 51160
- 2021.09.14 HHS PREP Act Declaration Amendment 9 Fact Sheet re preemption of SLTT state local tribal territorial government
- 2021.09.14 HHS PREP Act Declaration Amendment 9 Stakeholder Presentation
- 2021.09.30 HHS PREP Act Amendment 9 Technical Correction re ACIP CDC recommendations filed 2021.09.30, 86 FR 54696
- 2022.01.07 HHS PREP Act Amendment 10 additional qualified persons, pharmacy interns, administer seasonal influenza vaccines, signed 2022.01.04, 87 FR 982
- 2023.03.15 HHS PREP Act EUA Delegation of Authority and EUA Amendment, signed 2023.03.20, 88 FR 16645
- 2023.05.11 HHS PREP Act Amendment 11, distribution limitations, time, qualified persons, category of threat burden of seasonal influenza, 88 FR 30769
HHS Office of General Counsel Legal Opinions
- 2020.04.17 HHS OGC Legal Advisory Opinion 1, PREP Act, liability immunity, modified 2020.05.19
- 2020.05.19 HHS OGC Legal Advisory Opinion 2, 20-02, PREP Act, liability immunity
- 2020.10.23 HHS OGC Legal Advisory Opinion 3, 20-03, state preempt requirements pharmacists order administer vaccines
- 2020.10.23 HHS OGC Legal Advisory Opinion 4, 20-04 PREP Act, liability immunity, program planner, Authority Having Jurisdiction
HHS Office of Assistant Secretary for Health, Guidance to Pharmacists
- 2020.04.08 HHS OASH Guidance, pharmacists, Covid tests, PREP immunity
- 2020.08.31 HHS OASH Guidance, Covid tests, nursing homes, assisted living, congregate
- 2020.09.03 HHS OASH Guidance, pharmacists, pharmacy technicians, Covid-19 vaccines, PREP immunity
- 2020.10.20 HHS OASH Guidance, pharmacists, pharmacy technicians, pharmacy interns, childhood vaccines, Covid vaccines, Covid tests
- 2020.10.29 HHS OASH Guidance, pharmacies as business entity, qualified persons, liability immunity, preemption
___
https://bailiwicknews.substack.com/p/93-biochemical-weapons-to-decline